bsptv incorporating 4dct for pbs proton therapy of thoracic tumors-at ptcog54th meeting minglei kang

14
Beam specific PTV incorporating 4DCT for PBS proton therapy of thoracic tumors Minglei Kang, PhD Authors: Liyong Lin 1 , Minglei Kang 1 , Sheng Huang 1 , Rulon Mayer 2 , Andy Thomas 2 , James E McDonough1, Timothy D Solberg 1 , Charles Simone II 1 1 Department of Radiation Oncology, University of Pennsylvania 2 Henry Jackson Foundation Supported by the US Army Medical Research and Materiel Command under Contract Agreement No. DAMD17-W81XWH-07-2- 0121 and W81XWH-09-2-0174.

Upload: minglei-kang

Post on 13-Apr-2017

198 views

Category:

Health & Medicine


2 download

TRANSCRIPT

Page 1: BSPTV incorporating 4DCT for PBS proton therapy of thoracic tumors-at ptcog54th meeting Minglei Kang

Beam specific PTV incorporating 4DCT for PBS proton therapy of thoracic tumors

Minglei Kang, PhD

Authors: Liyong Lin1, Minglei Kang1, Sheng Huang1, Rulon Mayer2, Andy Thomas2, James E McDonough1, Timothy D Solberg1, Charles Simone II1

1Department of Radiation Oncology, University of Pennsylvania2Henry Jackson Foundation

Supported by the US Army Medical Research and Materiel Command under Contract Agreement No. DAMD17-W81XWH-07-2-0121 and W81XWH-09-2-

0174.

Page 2: BSPTV incorporating 4DCT for PBS proton therapy of thoracic tumors-at ptcog54th meeting Minglei Kang

2

Challenges for PBS to treat thoracic tumors Proton PBS treatment planning can achieve better organs

sparing than IMRT and DS techniques for thoracic tumors.

PBS is not a good choice.

Due to commercial TPSs are unable to calculate:

• (1). Accurate treatment margins to compensate for range uncertainties

• (2). PBS spots delivery interplay with organs motion

Chang, JY, Zhang X, Wang X et al. Int J Radiat Oncol Biol Phys., 65: 1087-1096, 2006Kang Y, Zhang X, Chang JY et al. Int J Radiat Oncol Biol.,67:906-914, 2007Lomax AJ. Phys Med Biol., 53: 1043, 2008Lomax AJ , Phys Med Biol; 53: 1027, 2008Zhang X, Li Y, Pan X et ,Int J Radiat Oncol Biol Phys., 77:357-366, 2010

Page 3: BSPTV incorporating 4DCT for PBS proton therapy of thoracic tumors-at ptcog54th meeting Minglei Kang

3

BSPTV: Beam specific planning target volume SPR: HU to stopping power ratio(SPR) conversion uncertainty Setup errors: cause cold or hot area. Motion: move the heterogeneity tissue into beam path to cause

overshoot or miss shootG=G300deg Slice No. 59 ,Y in Eclipse -508.5mm

X-axis

Z-ax

is

150 200 250 300 350

150

200

250

300

350

Park P C, Zhu X R, Lee AK et al. Int J Radiat Oncol Biol Phys; 82:329–36, 2012Flampouri S, Hoppe BS, Slopsema RL et al. Phys Med Biol; 59:4549-58. 2014

G=G300deg Slice No. 59 ,Y in Eclipse -508.5mm

X-axis

Z-ax

is

150 200 250 300 350

150

200

250

300

350

BSPTV

iCTV

Page 4: BSPTV incorporating 4DCT for PBS proton therapy of thoracic tumors-at ptcog54th meeting Minglei Kang

4

BSPTV: SPR, Setup errors and Motion

150 200 250 300 350

150

200

250

300

350

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

150 200 250 300 350

150

200

250

300

350

-0.9

-0.8

-0.7

-0.6

-0.5

-0.4

-0.3

-0.2

-0.1

0

X-axis

Z-ax

is

150 200 250 300 350

150

200

250

300

350

MIP-AVG

Mim IP-AVG

X-axis

Z-ax

is

150 200 250 300 350

150

200

250

300

350

iCTV

Distal M

Proximal M

Stopping power ratio: ± 3%, Setup errors: ±3 mm Motion quantification: 4DCT

Page 5: BSPTV incorporating 4DCT for PBS proton therapy of thoracic tumors-at ptcog54th meeting Minglei Kang

5

BSPTV: Sum 3 uncertainties Sum: linear or quadratic summation

• 3 uncertainties margins are displayed as Stopping power ratio, Setup and Motion, respectively.

G=G300deg Slice No. 59 ,Y in Eclipse -508.5mm

X-axis

Z-ax

is

150 200 250 300 350

150

200

250

300

350

400

G=G300deg Slice No. 59 ,Y in Eclipse -508.5mm

X-axis

Z-ax

is

150 200 250 300 350

150

200

250

300

350

G=G300deg Slice No. 59 ,Y in Eclipse -508.5mm

X-axis

Z-ax

is

150 200 250 300 350

150

200

250

300

350

G=G300deg Slice No. 59 ,Y in Eclipse -508.5mm

X-axis

Z-ax

is

150 200 250 300 350

150

200

250

300

350

Stopping power ratio(SPR)

Motion

Setup

Magenta: Linear Sum Yellow: Quadratic Sum

Page 6: BSPTV incorporating 4DCT for PBS proton therapy of thoracic tumors-at ptcog54th meeting Minglei Kang

6

BSPTV: Contribution of 3 uncertainties BSPTV volume: Linear and quadratic summation The volume of BSPTV by linear summation can be ~7% larger

than that by quadratic.

Page 7: BSPTV incorporating 4DCT for PBS proton therapy of thoracic tumors-at ptcog54th meeting Minglei Kang

7

BSPTV: Gantry angle optimization Minimizing the overlapped volumes along with the BSPTV will help spare lung,

heart and cord before the start of plan optimization.

G270

BSPTV overlap lung beam overlap lung beam overlap cord

Page 8: BSPTV incorporating 4DCT for PBS proton therapy of thoracic tumors-at ptcog54th meeting Minglei Kang

8

BSPTV applied in PBS for lung tumor 10 patients were re-planed using PBS based on BSPTV method Evaluation: 12 Perturbations were applied on 8 CT phase for

both PBS and DS plans• ±3% uncertainty in stopping power ratio (2×)• ± 3 mm for setup errors in x, y and z direction (2×3)• 8 CT phases(8×)

Total 96=12*8 evaluation plans for each patient

Page 9: BSPTV incorporating 4DCT for PBS proton therapy of thoracic tumors-at ptcog54th meeting Minglei Kang

9

The robustness of PBS and DS plans were evaluated. The bands are displayed to show all perturbations of iCTV.

BSPTV PBS plans vs. DS

Page 10: BSPTV incorporating 4DCT for PBS proton therapy of thoracic tumors-at ptcog54th meeting Minglei Kang

10

BSPTV PBS plans vs. DS Average (solid lines) and 25th and 75th percentile (dashed lines)

OAR DVHs for PBS (red) and DS (blue) of 10 patient plans.• Average uncertainties of DVH per patient are represented separately with red and

blue error bars over the average DVH.

Page 11: BSPTV incorporating 4DCT for PBS proton therapy of thoracic tumors-at ptcog54th meeting Minglei Kang

11

Interplay effect Having a breathing cycle of ~3.5 seconds with delivery durations of ~60 seconds and ~46 seconds

for the involved two beams. The spots’ time sequence was read out from the beam delivery log files. For different treatment fractions or beam paintings in the same fraction, the beams randomly start from a position of the 3.5-second breathing period. PBS spots were therefore grouped into the eight different breathing phases. One treatment plan was split into eight plans outside of Eclipse using our in-house Matlab program.

All doses were deformed to CT-50.

Energy(MeV) Spots

8 CT Phases

0% 12.5% 25% 37.5% 50% 62.5% 75% 87%110 38 38122 78 78145 104 78 26160 151 138 13176 197 14 170 13180 232 60 169 3190 265 66 175 24199 260 25 172 63202 279 93 186210 298 178 72 48218 304 96 192 16

MUs 567.0 42.53 75.83 124.1 55.70 50.68 45.63 98.35 74.12

Page 12: BSPTV incorporating 4DCT for PBS proton therapy of thoracic tumors-at ptcog54th meeting Minglei Kang

12

Interplay effect110%100%95%50%

Page 13: BSPTV incorporating 4DCT for PBS proton therapy of thoracic tumors-at ptcog54th meeting Minglei Kang

13

Conclusion

1. BSPTV can give more accurate treatment target volumes.

2. BSPTV can give best gantry angle before the plan optimization.

3. PBS+ BSPTV could achieve better organ sparing and improve target coverage using a repainting or multi-fraction method for treating thoracic tumors.

Page 14: BSPTV incorporating 4DCT for PBS proton therapy of thoracic tumors-at ptcog54th meeting Minglei Kang

14

Thank you.